Daniel B. Soland, VP, Chief Commercial Officer at VIROPHARMA INC (VPHM), bought 10,000 shares at $7.26 ($73K) on 2007-11-07, disclosed to the SEC on 2007-11-09.
Open-market purchase of $73k VPHM by VP, Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| IDRA | BUY | 2021-03-05 | $39K | — | Filing → |
| KALV | BUY | 2019-09-30 | $213K | — | Filing → |
| ACAD | BUY | 2018-03-02 | $235K | — | Filing → |